Effect of hypoglycemic therapy on fat metabolism

Abstract

Diabetes mellitus (DM type 2) is a chronic, progressive heterogeneous disease. According to the WHO, the number of patients with DM type 2 is nearly 370 million people. In 80-90% of cases [1] DM type 2 is associated with obesity. Abdominal (visceral) fat distribution which is typical of DM type 2 is characterized by dyslipidemia, insulin resistance and hypertension [2]. The combination of obesity and DM type 2 greatly aggravates the course, increasing the cost of treatment and rehabilitation. Despite numerous efforts in healthcare, compensation stage is registered in less than one third of patients with DM type 2.

Keywords

• сахарный диабет
• сахароснижающая терапия
• метформин
• инсулин
• вилдаглиптин
• diabetes
• hypoglycemic therapy
• metamorphine
• insulin
• vildagliptin